Eye Journal
Reply to ‘Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review’ – (Eye 29, 978 (July 2015))
Reply to ‘Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review’ Eye 29, 978 (July 2015). doi:10.1038/eye.2015.5 Authors: K Lee & Y-R Chung
Opaque intraocular lens implantation – (Eye 29, 978 (July 2015))
Opaque intraocular lens implantation Eye 29, 978 (July 2015). doi:10.1038/eye.2015.15 Authors: J W L Gong, U O’Colmain & C J MacEwen
Response to ‘Opaque intraocular lens implantation’ – (Eye 29, 980 (July 2015))
Response to ‘Opaque intraocular lens implantation’ Eye 29, 980 (July 2015). doi:10.1038/eye.2015.19 Authors: I H Yusuf, T H M Fung & C K Patel
Where is the junction of zone 2 and zone 3 temporal retina in RetCam images of acute retinopathy of prematurity? – (Eye 29, 981 (July 2015))
Where is the junction of zone 2 and zone 3 temporal retina in RetCam images of acute retinopathy of prematurity? Eye 29, 981 (July 2015). doi:10.1038/eye.2015.41 Author: B W Fleck
Topiramate maculopathy secondary to dose titration: first reported case – (Eye 29, 982 (July 2015))
Topiramate maculopathy secondary to dose titration: first reported case Eye 29, 982 (July 2015). doi:10.1038/eye.2015.45 Authors: P S Severn, R Symes, R Rajendram & B Pal